Cav1 is often downregulated or lost in breast, colon, ovarian, and lung cancers, suggesting a tumor-suppressive function (Bouras et al., 2004; Hino et al., 2003; Qian et al., 2019; Ren et al., 2021). This evidence concerns the gene CAV1 and neoplasm.